These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3300436)

  • 61. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol.
    Nathan RA; Bodman SF; Storms WW; Mingo TS
    Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma.
    Nathan RA; Bernstein IL; Bronsky EA; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Pinnas JL; Repsher LH
    J Allergy Clin Immunol; 1987 May; 79(5):822-9. PubMed ID: 3571773
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients.
    Pinnas JL; Bernstein IL; Bronsky EE; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Nathan RA; Repsher LH; Bhatt BD
    J Allergy Clin Immunol; 1987 May; 79(5):768-75. PubMed ID: 3571768
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.
    Nathan RA; Bronsky EA; Dockhorn RJ; Kemp JP
    Ann Allergy; 1994 Mar; 72(3):209-16. PubMed ID: 8129213
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bitolterol mesylate: a beta-adrenergic agent. Chemistry, pharmacokinetics, pharmacodynamics, adverse effects and clinical efficacy in asthma.
    Walker SB; Kradjan WA; Bierman CW
    Pharmacotherapy; 1985; 5(3):127-37. PubMed ID: 3895171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease.
    Friedel HA; Brogden RN
    Drugs; 1988 Jan; 35(1):22-41. PubMed ID: 3278878
    [TBL] [Abstract][Full Text] [Related]  

  • 67. (+/-) isoprenaline revisited: adverse effects of sympathomimetics in asthma.
    Hansel TT; Schwarz F; Villiger B; Morley J
    Agents Actions Suppl; 1993; 43():271-80. PubMed ID: 8368168
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.
    Kemp JP; Orgel HA; Grossman J; Reed CE; Tinkelman DG; Webb DR; Ziment I
    Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436
    [TBL] [Abstract][Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.